Skip to main content

Table 1 Baseline characteristics of the RA patients.

From: Anti-TNFα therapy transiently improves high density lipoprotein cholesterol levels and microvascular endothelial function in patients with rheumatoid arthritis: a Pilot Study

 

RA Patients

General Characteristics

 Age (years)

54 ± 15

 Sex female N (%)

15 (65)

 Height (cm)

165 ± 8

 BMI (kg/m2)

30 ± 6

Disease-related Characteristics

 RF Positive N (%)

20 (87)

 Disease duration (years)

11 ± 11

CVD Risk Factors

 Family history of CVD

12 (40)

 Diabetes

1 (3)

 Hypertension

6 (20)

 High Cholesterol

6 (20)

 Insulin Resistance

10 (33)

 Overweight

7 (23)

 Obese

13 (43)

Smoking Status

 Never smoked

11 (48.8)

 Previous smokers

7 (30)

 Current smokers

5 (22)

Rheumatologic Medications

 Methotrexate (%)

16 (70)

 Glucocorticosteroids (%)

6 (26)

 Medium dose GC (≥7.5 mg) (%)

13 (56)

 NSAIDs (%)

6 (26)

Cardiovascular Medications

 Anti-hypertensive treatment (%)

5 (22)

 Anti-hypercholesterolemic (%)

4 (17)

  1. Results are expressed as Number (%) and mean ± standard deviation. Diabetes = fasting glucose >7 mmol/l and/or oral hypoglycaemic medication or insulin use; hypertension = SBP >140 mmHg, DBP >90 mmHg or use of anti-hypertensive’s; high cholesterol = fasting cholesterol >4.1 mmol/l or use of anti-hypercholesterolemics; insulin resistance = homeostasis model assessment ≥2.5 or quantitative insulin sensitivity check index ≤0.333; overweight: BMI ≥ 23-27.9; obese: BMI ≥ 28. BMI: body mass index, RF: rheumatoid factor.